Viva Star Biosciences (Suzhou) Co. Ltd. has synthesized NLRP3 inflammasome inhibitors reported to be useful for the treatment of cryopyrin-associated periodic syndrome, multiple sclerosis, ...
The groundbreaking study that broadens the spectrum of cryopyrin-associated periodic syndromes was published in the American Journal of Ophthalmology. "In 1964, Dr. Olavi Valle, a Finnish ... Business Wire: Inzomelid completes Phase I studies and shows positive results in the treatment of Cryopyrin-Associated Periodic Syndrome (CAPS) Inzomelid completes Phase I studies and shows positive results in the treatment of Cryopyrin-Associated Periodic Syndrome (CAPS) Cryopyrin-associated autoinflammatory syndromes, also called cryopyrin-associated periodic syndromes, are a group of three diseases in which the protein called cryopyrin, or NLRP3, is defective.
cryopyrin-associated periodic fever, It is ... Business Wire: FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) FDA Grants Orphan Drug Designation for Inflazome’s Inzomelid for the Treatment of Cryopyrin-Associated Periodic Syndromes (CAPS) Ilaris (canakinumab) is a brand-name prescription medication. The Food and Drug Administration (FDA) has approved it to treat certain periodic fever conditions and certain types of Still’s disease.
